Case Study: An End-to-End Solution for Large Scale Adenovirus Manufacturing

With several recent FDA approvals and a strong drug pipeline, the gene therapy market is coming of age and providing new hope for patients. As demand for these new therapies increases, a robust and scalable manufacturing process is critical. In this webinar, we will present an end user case study which illustrates the challenges and solutions to scale both the upstream and downstream process steps required to manufacture adenoviruses.

 

Participants will learn how to:

 

• Accelerate time to market for adenovirus manufacturing

• Design the process for scalability

• Reduce downstream processing time from 3 - 4 days to 1 day

Speakers

clive glover

Clive Glover, PhD

 

Senior Marketing Manager, Cell & Gene Therapy

Pall Biotech

Rachel Legmann

Rachel Legmann, PhD

 

Senior Manager, Process Development Services

Pall Biotech

Case Study: An End-to-End Solution for Large Scale Adenovirus Manufacturing

Maximize Speed to Market Flexibility of Single-Use for Gene Therapy Manufacturing

More Biotech Webinars
Our webinars keep you informed on the latest products and technologies, current industry topics, the latest trends and a range of innovations and solutions to help continuously improve your processes.
November 2020

From November 3rd to November 19th

 

There is no single vaccine manufacturing approach. There are, however, flexible technologies that can meet each of the challenges during process development and at GMP scale.

 

Accelerating vaccine development and manufacturing by coupling research advances in vaccine technology with systems that support agility through a Quality by Design approach is critical to deliver life-saving immunizations to those in need globally.

 

Diversity in the type of vaccine antigen, along with the inherent variation in the targets, have created challenges for vaccine manufacturers when compared to a relatively small number of platform processes that exist.

 

There are flexible technologies that can meet each of the challenges during PD and at GMP scale.

 

Join this webinar series and learn more about securing process quality with flexible manufacturing solutions.

 

Webinars available

 

  • Vaccines development, regulations and manufacturing Parts 1 & 2

 

  • Developing scalable upstream workflows for recombinant and viral vaccine processes

 

  • Downstream process development for vaccine manufacturing

 

  • Implementing single-use technologies in formulation and filling of vaccines
Register